Articles

August 15, 2024 Alnylam Named a Humankind 100 Company for the 3rd Year in a Row Alnylam has been named to the HumanKind 100 list for the 2nd year in a row and we’re pleased to have moved up in the rankings from #97 in 2022 to #76 in 2023. Read More ›
May 7, 2024 Alnylam Publishes 2023 Corporate Responsibility Report Alnylam's 2023 Corporate Responsibility Report details our corporate responsibility and ESG efforts and progress. Read More ›
April 26, 2024 Better Together: Alnylam and Organized Customer Health Systems Want to Improve Access and ... Alnylam's Head of Strategic Accounts discusses the rise of the Integrated Delivery Network and manufacturer relationship Read More ›
April 25, 2024 Our Commitment to Patients Means Never Stop Evolving - Our Patient Access Philosophy Tolga Tanguler, Alnylam's Chief Commercial Officer discusses Alnylam's Patient Access Philosophy and approach to access Read More ›
April 16, 2024 Alnylam Ranked #3 on LinkedIn's List of Top Midsize Companies for 2024 Alnylam is proud to be included on LinkedIn's Top Companies list for 2024. Read More ›
April 2, 2024 2023 Year in Review: CEO Yvonne Greenstreet Reflects on a Year of Substantial Growth and P ... Alnylam CEO Yvonne Greenstreet reflects on the company's accomplishments in 2023 and highlights of the 2023 annual report. Read More ›
February 29, 2024 Alnylam Named to Human Rights Campaign’s Corporate Equality Index Alnylam has achieved a score of 90 out of 100 on the Human Rights Campaign's (HRC) 2023-2024 Corporate Equality Index (CEI) based on our US policies, practices, Read More ›
February 21, 2024 Health Equity Symposium Highlights Innovative Solutions to Complex Health Challenges As part of Alnylam Challengers, we aim to connect entrepreneurs, community partners and our employees to explore the challenges we collectively face and highlig Read More ›
December 19, 2023 Community Spotlight: GenUnity – A Community-Based Model of Change Through Alnylam Challengers, Alnylam partners with organizations like GenUnity which works to unlock community-centered innovation Read More ›
December 14, 2023 R&D Day 2023 Recap: Following the Science to Deliver on the Promise of RNAi Therapeutics During our 2023 R&D Day, our leadership discussed several exciting innovations and provided a look ahead at the rapid growth and evoltuion of our pipeline. Read More ›
Subscribe to Articles